Literature DB >> 3818784

Clinical trial of attenuated vaccinia virus AS strain in the treatment of advanced adenocarcinoma. Report on two cases.

S Arakawa, G Hamami, K Umezu, S Kamidono, J Ishigami, S Arakawa.   

Abstract

Two cases of advanced adenocarcinoma treated with attenuated vaccinia virus AS strain are reported. One was a primary lung adenocarcinoma with metastatic lesions in brain, right kidney, and rib. The other was a left renal adenocarcinoma with multiple lung and vertebral metastases. In both patients, good antitumor effects against lung and bone lesions were obtained, respectively, and no adverse reactions were noted. Therefore, treatment of patients with AS vaccinia virus appears to suppress the growth of tumor cells without adverse effects on normal human cells. This is the first report to describe the effects of attenuated vaccinia virus AS strain on human cancer.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3818784     DOI: 10.1007/bf00389974

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  6 in total

1.  An investigation into the purifying effect of a fluorocarbon on vaccinia virus.

Authors:  M A EPSTEIN
Journal:  Br J Exp Pathol       Date:  1958-08

2.  Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases.

Authors:  D G Skinner; R B Colvin; C D Vermillion; R C Pfister; W F Leadbetter
Journal:  Cancer       Date:  1971-11       Impact factor: 6.860

3.  The augmentation of tumor-specific immunity by virus help. I. Demonstration of vaccinia virus-reactive helper T cell activity involved in enhanced induction of cytotoxic T lymphocyte and antibody responses.

Authors:  H Fujiwara; Y Shimizu; Y Takai; N Wakamiya; S Ueda; S Kato; T Hamaoka
Journal:  Eur J Immunol       Date:  1984-02       Impact factor: 5.532

4.  The effect of attenuated vaccinia virus AS strain on N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric cancer in rats.

Authors:  S Arakawa; K Fukai
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

5.  The augmentation of tumor-specific immunity by virus help. II. Enhanced induction of cytotoxic T lymphocyte and antibody responses to tumor antigens by vaccinia virus-reactive helper T cells.

Authors:  Y Shimizu; H Fujiwara; S Ueda; N Wakamiya; S Kato; T Hamaoka
Journal:  Eur J Immunol       Date:  1984-09       Impact factor: 5.532

6.  Validation of the tumor, nodes and metastasis classification of renal cell carcinoma.

Authors:  B Bassil; D E Dosoretz; G R Prout
Journal:  J Urol       Date:  1985-09       Impact factor: 7.450

  6 in total
  7 in total

1.  Oncolytic Viruses to Treat Ovarian Cancer Patients - a Review of Results From Clinical Trials.

Authors:  A D Hartkopf; T Fehm; M Wallwiener; U Lauer
Journal:  Geburtshilfe Frauenheilkd       Date:  2012-02       Impact factor: 2.915

2.  Regression of human pancreatic tumor xenografts in mice after a single systemic injection of recombinant vaccinia virus GLV-1h68.

Authors:  Yong A Yu; Charles Galanis; Yanghee Woo; Nanhai Chen; Qian Zhang; Yuman Fong; Aladar A Szalay
Journal:  Mol Cancer Ther       Date:  2009-01       Impact factor: 6.261

3.  In silico trials predict that combination strategies for enhancing vesicular stomatitis oncolytic virus are determined by tumor aggressivity.

Authors:  Adrianne L Jenner; Tyler Cassidy; Katia Belaid; Marie-Claude Bourgeois-Daigneault; Morgan Craig
Journal:  J Immunother Cancer       Date:  2021-02       Impact factor: 13.751

Review 4.  Viruses as nanomedicine for cancer.

Authors:  Narayanasamy Badrinath; Jeong Heo; So Young Yoo
Journal:  Int J Nanomedicine       Date:  2016-09-21

Review 5.  Genetically Engineered Vaccinia Viruses As Agents for Cancer Treatment, Imaging, and Transgene Delivery.

Authors:  Dana Haddad
Journal:  Front Oncol       Date:  2017-05-23       Impact factor: 6.244

6.  Tachypleus tridentatus Lectin Enhances Oncolytic Vaccinia Virus Replication to Suppress In Vivo Hepatocellular Carcinoma Growth.

Authors:  Gongchu Li; Jianhong Cheng; Shengsheng Mei; Tao Wu; Ting Ye
Journal:  Mar Drugs       Date:  2018-06-07       Impact factor: 5.118

7.  A Three-Dimensional Organoid Model of Primary Breast Cancer to Investigate the Effects of Oncolytic Virotherapy.

Authors:  Mary E Carter; Andreas D Hartkopf; Anna Wagner; Léa L Volmer; Sara Y Brucker; Susanne Berchtold; Ulrich M Lauer; André Koch
Journal:  Front Mol Biosci       Date:  2022-02-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.